China SXT Pharmaceuticals, Inc.
SXTC
$1.46
-$0.0396-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -211.61% | 0.00% | -112.17% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -79.88% | 0.00% | -31.67% | 0.00% |
| Total Amortization of Deferred Charges | 0.00% | 389.14% | 0.00% | 10.50% | 0.00% |
| Total Other Non-Cash Items | 0.00% | 3,613.22% | 0.00% | 100.47% | 0.00% |
| Change in Net Operating Assets | 0.00% | 69.80% | 0.00% | -7.03% | 0.00% |
| Cash from Operations | 0.00% | 27.19% | 0.00% | -0.65% | 0.00% |
| Capital Expenditure | 0.00% | -- | -- | -- | 0.00% |
| Sale of Property, Plant, and Equipment | 0.00% | -38.42% | 0.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Investing | 0.00% | -43.35% | 0.00% | 497.06% | 0.00% |
| Total Debt Issued | 0.00% | -95.81% | 0.00% | 437.96% | 0.00% |
| Total Debt Repaid | 0.00% | -2,252.69% | 0.00% | -113.60% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | 0.00% | 38.77% | 0.00% |
| Cash from Financing | 0.00% | -83.94% | 0.00% | 293.88% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -212.66% | 0.00% | 341.68% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -105.96% | 0.00% | 951.23% | 0.00% |